文献速递神经肿瘤

胶质母细胞瘤患者嗜酸性粒细胞与嗜碱性粒细胞相关指标分析及其与生存的相关性

An Analysis of Eosinophil- and Basophil-Based Indices in Patients with Glioblastoma and their Correlation with Survival.
PubMed 文献 · World Neurosurg · 2022-11-09

本研究为对前瞻性维护数据库的回顾性分析,比较胶质母细胞瘤患者与健康对照的嗜酸性粒细胞及嗜碱性粒细胞相关指标,并分析其与患者因素、肿瘤因素及总生存的相关性。结果显示所有指标在患者中均有改变,绝对嗜酸性粒细胞计数在预后较好组更高,中性粒细胞/嗜酸性粒细胞比值更低;总淋巴细胞计数/嗜碱性粒细胞比值和绝对嗜酸性粒细胞计数在多因素分析中独立预测生存。

要点

  • 胶质母细胞瘤患者各项嗜酸性粒细胞及嗜碱性粒细胞相关指标均与健康对照不同。
  • 绝对嗜酸性粒细胞计数在预后较好组更高,中性粒细胞/嗜酸性粒细胞比值更低。
  • 总淋巴细胞计数/嗜碱性粒细胞比值和绝对嗜酸性粒细胞计数独立预测生存。

核心结论

  • 绝对嗜酸性粒细胞计数在预后较好组中持续更高,作者认为该指标可能被纳入胶质母细胞瘤的预后模型。

研究设计与样本

  • 本研究为对前瞻性维护数据库的回顾性分析,数据来自选定患者的电子病历,包括患者相关因素、肿瘤相关因素、血常规及生存数据。

主要发现

  • 与健康对照相比,胶质母细胞瘤患者所有嗜酸性粒细胞及嗜碱性粒细胞相关指标均发生改变。
  • 在预后较好组中,绝对嗜酸性粒细胞计数更高,中性粒细胞/嗜酸性粒细胞比值更低;预后较好组包括体能状态较好者、就诊时无颅内压增高或意识改变者、ATRX保留且p53未过表达的肿瘤患者以及长期存活者。
  • 多因素分析中,总淋巴细胞计数/嗜碱性粒细胞比值和绝对嗜酸性粒细胞计数均独立预测生存。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma (GBM) is the most frequently diagnosed malignant brain tumor in adults. GBM is usually lethal within 24 months of diagnosis, despite aggressive multimodality treatment. Although it has been established that cancer-related inflammation is associated with worse outcomes, the role of eosinophils, basophils, atopy, and allergy in glioma biology is only gradually being delineated. In this study, we aimed to examine if eosinophil-based and basophil-based indices were altered in patients with GBM compared with healthy controls. We also aimed to study if there was any correlation between these indices and patient-related and tumor-related factors and survival. METHODS: This study was a retrospective analysis of prospectively maintained databases. Data pertaining to patient-related and tumor-related factors, hemograms, and survival data were obtained from the electronic medical records of selected patients. Correlations between eosinophil-based and basophil-based indices and these factors were studied, as was the association with overall survival. RESULTS: All the indices were altered in patients with GBM compared with normal healthy controls. The absolute eosinophil count was higher and the neutrophils/eosinophils ratio was lower in the better prognosis groups: those with better performance status; those without features of increased intracranial pressure or altered sensorium at presentation; those with ATRX-retained tumors that did not overexpress p53; and in the long-term survivors. The total lymphocyte count/basophils ratio and the absolute eosinophil count both independently predicted survival in a multivariate analysis. CONCLUSIONS: The absolute eosinophil count was consistently higher in the better prognosis groups and is likely to be incorporated into prognostic models for GBM.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Madhugiri VS, Venkatesan S, Dutt A, et al. An Analysis of Eosinophil- and Basophil-Based Indices in Patients with Glioblastoma and their Correlation with Survival. World Neurosurg. 2022. PMID: 36368458. doi:10.1016/j.wneu.2022.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。